EXECUTIVE EMPLOYMENT AGREEMENT BY AND BETWEEN HORIZON PHARMA, INC., HORIZON PHARMA USA, INC. AND PAUL W. HOELSCHEREmployment Agreement • June 18th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (hereinafter referred to as the “Agreement”), is entered into by and between Horizon Pharma, Inc., a Delaware corporation, and its wholly owned subsidiary, Horizon Pharma USA, Inc., a Delaware corporation, each having a principal place of business at 520 Lake Cook Road, Suite 520, Deerfield, IL 60015, (hereinafter referred to together as the “Company”) and Paul W. Hoelscher (hereinafter referred as to the “Executive”). The terms of this Agreement shall remain confidential until the Executive’s first day of employment with the Company (the “Date of Hire”), which will be on June 23, 2014 and which is also the effective date of this Agreement (the “Effective Date”)
HORIZON PHARMA, INC. EXECUTIVE EMPLOYMENT AND TRANSITION AGREEMENTEmployment and Transition Agreement • June 18th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • Illinois
This Executive Employment and Transition Agreement (“Transition Agreement”), replaces and supersedes that certain Amended and Restated Executive Employment Agreement (the “Employment Agreement”) dated July 27, 2010 and that certain First Amendment to Amended and Restated Executive Employment Agreement (the “First Amendment”) dated January 16, 2014 (collectively the “Prior Agreements”), by and among Horizon Pharma, Inc., a Delaware corporation, and its wholly owned subsidiary, Horizon Pharma USA, Inc., a Delaware corporation (hereinafter referred to together as the “Company”), and Robert J. De Vaere (the “Executive”). This Transition Agreement shall become effective on the “Effective Date” specified in Section 10 below.
FIRST AMENDMENT TO TRANSACTION AGREEMENT AND PLAN OF MERGERTransaction Agreement and Plan of Merger • June 18th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO TRANSACTION AGREEMENT AND PLAN OF MERGER (this “Amendment”) is dated as of June 12, 2014, and is entered into by and between Horizon Pharma, Inc., a Delaware corporation (“Buyer”), and Vidara Therapeutics Holdings LLC, a Delaware limited liability company (“Holdings”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement (defined below).
